ESCI期刊Cardiovascular Revascularization Medicine 2024/2025影響因子:1.678 (CARDIOVASC REVASCULA) (1553-8389). (CARDIAC & CARD

只看該作者 · 發(fā)表于 2025-3-27 01:59:21

Submitted on: 01 June 2015. Revised on: 16 September 2015. Accepted on: 09 November 2015. ___________________Cardiovascular Revascularization Medicine

只看該作者 · 發(fā)表于 2025-3-27 06:33:22

Submitted on: 08 June 2022. Revised on: 17 August 2022. Accepted on: 01 October 2022. ___________________Cardiovascular Revascularization Medicine

只看該作者 · 發(fā)表于 2025-3-27 12:17:09

Submitted on: 08 October 2010. Revised on: 31 December 2010. Accepted on: 17 January 2011. ___________________Cardiovascular Revascularization Medicine

只看該作者 · 發(fā)表于 2025-3-27 17:29:08

Submitted on: 26 June 2000. Revised on: 02 October 2000. Accepted on: 15 October 2000. ___________________Cardiovascular Revascularization Medicine

只看該作者 · 發(fā)表于 2025-3-27 18:37:22

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-4 21:38
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved